reveromycin a has been researched along with Multiple Myeloma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, M; Bat-Erdene, A; Cui, Q; Endo, I; Harada, T; Hiasa, M; Kawatani, M; Matsumoto, T; Miki, H; Mitsui, Y; Oda, A; Osada, H; Oura, M; Sogabe, K; Sumitani, R; Tanaka, E; Tenshin, H; Teramachi, J; Watanabe, K | 1 |
1 other study(ies) available for reveromycin a and Multiple Myeloma
| Article | Year |
|---|---|
Reveromycin A, a novel acid-seeking agent, ameliorates bone destruction and tumor growth in multiple myeloma.
Topics: Humans; Multiple Myeloma; Osteoclasts; Osteolysis; Pyrans; Spiro Compounds | 2021 |